TSXV:CZO - Post Discussion
Post by
prophetoffactz on Apr 30, 2024 8:33am
Category breaker?
With the 5X PGX scale-up having completed 3 trial runs and "almost complete" and potential Health Canada approval for commercial sales this year is this next?
"Protocol designed for a head-to-head study in animals for testing immune properties of PGX-YBG against a commercial formulation." Novermber 29, 2023 news release
Previous lab results suggest PGX-YBG is potentially multi-fold more immune stimulative than competing products. Could a head-to-head animal trial drive the message home that PGX-YBG may not have only disrupted the yeast beta glucan immune stimulation market but transcended it into the much larger immune stimulation market. PGX-YBG could also be the only inhalable yeast beta glucan.
Be the first to comment on this post